-
Product Insights
EnBW Hohe See
EnBW Hohe See is an offshore wind project located in North Sea, Germany. The project is owned by Canada Pension Plan Investment Board; Enbridge Inc; EnBW Energie Baden-Wurttemberg AG and was developed by Enbridge Inc; EnBW Energie Baden-Wurttemberg AG. The project came online in 2019. Empower your strategies with our EnBW Hohe See report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to...
-
Sector Analysis
NewSix Nations (Rugby Championship), 2024 – Event Analysis
An analysis of the recent 2024 Six Nations, including a look at its sponsorship portfolio, broadcasters, attendance and ticketing. The Six Nations 2024 generated an estimated $177.68 million in media revenue from competing nations. In the United Kingdom, ITV have the broadcasting rights for all the home matches for England. Ireland, France, and Italy, while the BBC showed the coverage of games in Cardiff at the Principality Stadium and Edinburgh at Murrayfield for Wales and Scotland, respectively. England's defeat to...
-
Product Insights
NewLikelihood of Approval Analysis for Retinal Degeneration
Overview How likely is it that the drugs in Retinal Degeneration will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Retinal Degeneration Overview Retinal degeneration refers to a group of diseases that...
-
Product Insights
NewLikelihood of Approval Analysis for Vision Disorders
Overview How likely is it that the drugs in Vision Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vision Disorders Overview Vision disorders are characterized by poor or unclear vision...
-
Product Insights
NewLikelihood of Approval Analysis for Psychosis
Overview How likely is it that the drugs in Psychosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Psychosis Overview Psychosis is a condition that affects the mind and causes a...
-
Consumer Insights
NewSpain Apparel Consumer Insights – Who Shops, What do they Shop, How do they Shop and Why do they Shop
This report provides detailed consumer insights into Spanish apparel market. It centers on consumer sentiment, categories purchased, channel usage, motivations for purchasing, purchase frequency and the most popular global brands. Spain’s inflation rate is softening, slowing to 3.8% in December 2023 from 8.3% in 2022, driving less than half of consumers to expect the economy to get worse in the next six months. In 2023, 81.4% of apparel shoppers bought items instore, while 61.1% purchased online, as consumers favoured being...
-
Sector Analysis
NewGuatemala Beverages Consumption Trends and Forecasts Tracker, Q4 2023
Guatemala Beverages Market Report Overview The Guatemala beverages market size was valued at 1.58 billion liters (BL) in Q4 2023. Guatemala will see a growth in terms of GDP in 2024. In the next five years, the health & wellness trend will limit the volume growth of categories with a high sugar content. The Guatemala beverages market research report has recorded essential data on key products, their categories, and their consumption volume in the country for Q4 2023. Furthermore, the...
-
Product Insights
NewLikelihood of Approval Analysis for Metastatic Uveal Melanoma
Overview How likely is it that the drugs in Metastatic Uveal Melanoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Uveal Melanoma Overview Metastatic uveal melanoma is a rare and...